Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 13, Issue 10, Pages 1305-1317
Publisher
Informa Healthcare
Online
2014-08-19
DOI
10.1517/14740338.2014.947958
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Teriflunomide for the Treatment of Relapsing Multiple Sclerosis
- (2014) Luigi Brunetti et al. ANNALS OF PHARMACOTHERAPY
- Multiple Sclerosis Disease-Modifying Therapy Prescribing Patterns in Ontario
- (2014) James J. Marriott et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Presentation and Outcomes with Clinically Apparent Interferon Beta Hepatotoxicity
- (2013) Robert J. Fontana et al. DIGESTIVE DISEASES AND SCIENCES
- Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland
- (2013) Einar S. Björnsson et al. GASTROENTEROLOGY
- Cancer risk in multiple sclerosis: findings from British Columbia, Canada
- (2012) Elaine Kingwell et al. BRAIN
- Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury–Past, Present, and Future
- (2012) J R Senior CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
- (2012) Afsaneh Shirani et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Suspected autoimmune hepatitis and primary biliary cirrhosis unmasked by interferon-beta in a multiple sclerosis patient
- (2012) Kaarina Kowalec et al. Multiple Sclerosis and Related Disorders
- Serum Levels of Alanine Aminotransferase Decrease With Age in Longitudinal Analysis
- (2011) Mamie H. Dong et al. Clinical Gastroenterology and Hepatology
- Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
- (2011) G P Aithal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles
- (2011) M. Isabel Lucena et al. GASTROENTEROLOGY
- Mechanisms of drug-induced liver injury: from bedside to bench
- (2011) Shannan Tujios et al. Nature Reviews Gastroenterology & Hepatology
- Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method
- (2010) Don C. Rockey et al. HEPATOLOGY
- High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study
- (2010) S Chan et al. Multiple Sclerosis Journal
- New perspectives in the natural history of multiple sclerosis
- (2010) H. Tremlett et al. NEUROLOGY
- Pharmacogenomics: the importance of accurate phenotypes
- (2010) David Gurwitz et al. PHARMACOGENOMICS
- Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex
- (2009) M. Isabel Lucena et al. HEPATOLOGY
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
- (2009) Ann K Daly et al. NATURE GENETICS
- Drug-induced liver injury: Is it somehow foreseeable?
- (2009) Giovanni Tarantino et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice
- (2008) Einar Björnsson et al. JOURNAL OF HEPATOLOGY
- Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination?
- (2008) Giada Pietrosi et al. TRANSPLANT INTERNATIONAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started